Bevacizumab/povidone-iodineVarious complications: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1577卷 / 1期

关键词：

D O I：

10.1007/s40278-015-10478-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：65 / 65

相关论文

共 50 条

[41] Busulfan/ciclosporin/lorazepamDrug toxicity with neurological complications: 7 case reports
[J]. Reactions Weekly, 2014, 1528 (1) : 46 - 46
[42] Multiple drugsVenoocclusive liver disease with various complications: 7 case reports
[J]. Reactions Weekly, 2017, 1670 (1) : 200 - 200
[43] Doxycycline/povidone-iodineLack of efficacy: 2 case reports
[J]. Reactions Weekly, 2022, 1934 (1) : 174 - 174
[44] Povidone iodineIrritant purpuric contact dermatitis: 2 case reports
[J]. Reactions Weekly, 2019, 1770 (1) : 332 - 332
[45] Bevacizumab/fluorouracilOral mucositis: 3 case reports
[J]. Reactions Weekly, 2011, 1370 (1) : 11 - 11
[46] Bevacizumab/carmustineVarious toxicities: 8 case reports
[J]. Reactions Weekly, 2018, 1690 (1) : 43 - 43
[47] Bevacizumab/doxorubicinMyelosuppression and hypertension: 3 case reports
[J]. Reactions Weekly, 2022, 1888 (1) : 103 - 103
[48] Bevacizumab/cetuximabPulmonary toxicities: 3 case reports
[J]. Reactions Weekly, 2021, 1868 (1) : 113 - 113
[49] Bevacizumab/ranibizumab/triamcinoloneEndophthalmitis: 21 case reports
[J]. Reactions Weekly, 2011, 1377 (1) : 11 - 11
[50] Bevacizumab/ranibizumabOcular hypertension: 10 case reports
[J]. Reactions Weekly, 2021, 1877 (1) : 71 - 71

← 1 2 3 4 5 →